Wouldn’t it be great if you could stay strong, flexible and fit with a low-risk exercise program and have some fun at the same time? You can! Swimming is a great exercise for people with hemophilia and other bleeding disorders.
The NHF Inhibitor Education Summits provided an opportunity to learn more about having hemophilia with an inhibitor—and to connect with people familiar with those challenges.
The National Hemophilia Foundation has counterparts across the country advocating for the needs of patients with blood disorders. These groups had never met until the first National Conference on Blood Disorders in Public Health.
Scientific literature can be intimidating, even to people with hemophilia and other bleeding disorders. Not so for three consumers selected to attend the National Hemophilia Foundation’s new therapies workshop.
Clinical trials—whether they’re testing a new drug or treatment, measuring the safety of an experimental therapy or fine-tuning dosages of an existing product—move science and medicine forward.
Genotyping could become the catalyst for the National Hemophilia Foundation to fulfill its mission to find better treatments and cures for people with bleeding disorders.
By Connie Miller, PhD, and J. Michael Soucie, PhD | 04.20.2010
As technology has advanced and more patients have been genotyped worldwide, it has become clear that knowledge of genotype will play a key role in clinical care.
A lot has changed in the more than 30 years since hemophilia treatment centers (HTCs) were started as a way to better diagnose and treat people with bleeding disorders.
The National Hemophilia Foundation (NHF) is pleased to announce its research and fellowship award winners, who were honored at NHF’s 61st Annual Meeting in October 2009.
